Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
John Leonard
Biotech
Intellia now has the data for gene editing durability question
Intellia proved last year that gene editing can work in humans. But a lingering question was, for how long? The data are now in.
Annalee Armstrong
Feb 28, 2022 4:01pm
Intellia bags option on Kyverna’s autoimmune CAR-T prospect
Jan 5, 2022 7:30am
Not for sale: Intellia CEO Leonard talks dealmaking
Oct 19, 2021 11:15am
